The Journal of Child and Adolescent Psychopharmacology
PANS/PANDAS treatment guidelines are included in this in this edition of JCAP. The guidelines, drafted by 44 medical and scientific leaders who represent 23 different academic institutions from across the US, Canada and Australia, represent a national standard of care for treating patients with PANS/PANDAS. The authors include experts in the fields of child psychiatry, pediatrics, infectious diseases, microbiology, neurology, neuroimmunology, immunology and rheumatology.
Download The Articles Below
- Overview of treatment of PANS – an introduction
http://online.liebertpub.com/doi/pdf/10.1089/cap.2017.0042 - Psychiatric and behavioral interventions
http://online.liebertpub.com/doi/pdf/10.1089/cap.2016.0145 - Use of Immunomodulatory therapies
http://online.liebertpub.com/doi/pdf/10.1089/cap.2016.0148 - Treatment and prevention of infections
http://online.liebertpub.com/doi/pdf/10.1089/cap.2016.0151
Schedule Your Personal Phone Consultation
Learn more about how the Cunningham Panel™ of tests can assist you in diagnosing treatable autoimmune encephalopathies characterized by abnormal neuropsychiatric behaviors. Schedule your personal phone consultation with a Moleculera Labs clinical staff member by completing the form below or call Amy Cross, RN, at 405-239-5254.